Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Le Berre, C; Peyrin-Biroulet, L

Peyrin-Biroulet, L (corresponding author), Univ Lorraine, Nancy Univ Hosp, Dept Gastroenterol, 1 Allee Morvan, F-54511 Vandoeuvre Les Nancy, France.; Peyrin-Biroulet, L (corresponding author), Univ Lorraine, Nancy Univ Hosp, INSERM NGERE U1256, 1 Allee Morvan, F-54511 Vandoeuvre Les Nancy, France.

GASTROENTEROLOGY, 2021; 160 (5): 1452

Abstract

BACKGROUND AND AIMS: Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic and disabling disor......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索